Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04848727 · ClinicalTrials.gov registry record
Detection of Atelectasis or Pneumothorax and Resolution With Electrical Impedance Tomography (EIT) in Newborn Infants
A clinical trial, sponsored by Sharp HealthCare.
- Completed
- Registry status
- 20
- Enrollment target
NCT04848727: Completed study, sponsored by Sharp HealthCare.
NCT04848727 is a clinical trial that has completed, run by Sharp HealthCare. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04848727 has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
To validate the benefits of recognizing asymmetric lung disease like atelectasis and pneumothorax in neonatal respiratory distress syndrome using electrical impedance tomography
Primary Outcome
Atelectasis will be calculated using the percentage of the lung fields that are not engaged in tidal volume.(VT)
Interventions
- OTHER Detecting asymmetric lung disease like atelectasis or pneumothorax with electrical impedance tomography (EIT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-08-06 |
| Est. Completion | 2022-06-07 |
What the finished NCT04848727 record still lists
NCT04848727 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Detecting asymmetric lung disease like atelectasis or pneumothorax with electrical impedance tomography (EIT) is the first listed.
NCT04848727 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04848727 about?
NCT04848727 is a clinical study titled "Detection of Atelectasis or Pneumothorax and Resolution With Electrical Impedance Tomography (EIT) in Newborn Infants". To validate the benefits of recognizing asymmetric lung disease like atelectasis and pneumothorax in neonatal respiratory distress syndrome using electrical impedance tomography
What is the current status of trial NCT04848727?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-08-06. Estimated completion is 2022-06-07.
What interventions are being tested in trial NCT04848727?
The interventions under investigation include: Detecting asymmetric lung disease like atelectasis or pneumothorax with electrical impedance tomography (EIT) (OTHER).
Who is sponsoring clinical trial NCT04848727?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI